In addition, alpha fetoprotein (AFP)—a serum biomarker associated with GSD1a-related HCA/HCC development54—was also partially reduced upon treatment with hG6PC S298C mRNA (Supplementary Fig. 4b). Here, G6PC1 is linked to hepatocellular carcinoma.